Harms of screening mammography for breast cancer in Japanese women

Breast Cancer

Volumn 20, Issue 4, 2013, Pages 310-315

  Kasahara, Yoshio ^a   Kawai, Masaaki ^b   Tsuji, Ichiro ^b   Tohno, Eriko ^c   Yokoe, Takao ^d   Irahara, Minoru ^e   Tangoku, Akira ^e   Ohuchi, Noriaki ^b  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Shibukawa General Hospital   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Breast cancer screening; Harm; Mammography

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EFFECTIVENESS; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; HEALTH HAZARD; HUMAN; IMAGE ANALYSIS; JAPANESE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; JAPAN; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; UNITED STATES;

EID: 84892790374     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-012-0333-6     Document Type: Article

References (14)

1. Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam Med. 2011;43:248-53.
2. Brodersen J, Jørgensen KJ, Gøtzsche PC. The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn. 2010;120:89-94.
3. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-37.
4. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-26.
5. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. Am J Roentgenol. 2011;196:W112-6.
6. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-19.
7. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst. 1986;77:317-20.
8. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-12.
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M. Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-60.
10. Bjurstam N, Björneld L, Warwick J, Sala E, Duffy SW, Nyström L, et al. The Gothenburg breast screening trial. Cancer. 2003;97: 2387-96.
11. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995;75:2507-17.
12. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:1490-9.
13. Gutwein LG, Ang DN, Liu H, Marshall JK, Hochwald SN, Copeland EM, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011;202:127-32.
14. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. West J Med. 2000;173:307-12.